揭开血液恶性瘤中的ADC耐药性:挑战和新的前沿
Monica Armanious1, Farida K Gebreel1, Reem W Algendy1
1Department of Pharmacology and Toxicology, Faculty of Pharmacy and Biotechnology, German University in Cairo, Cairo 11835, Egypt.
Pathology, research and practice
|December 31, 2025
概括
抗体-药物合物 (ADCs) 在治疗血液癌症方面表现有前途,但面临耐药性. 本综述详细介绍了ADC耐药性机制和改善血液恶性瘤长期疗效的策略.
科学领域:
- 在瘤学瘤学.
- 药理学 药理学是指药理学的学科.
- 癌症生物学 癌症生物学
背景情况:
- 抗体-药物结合物 (ADC) 代表了血液恶性瘤的显著治疗进步,提供有针对性的细胞杀死,降低了全身毒性.
- 尽管最初取得了成功,但对ADCs的耐药性发展对它们在治疗血液癌症中的持续临床益处构成了主要障碍.
研究的目的:
- 综合审查在血液癌症中驱动抗体-药物联合体 (ADC) 耐药性的多种机制.
- 探索瘤微环境对ADC疗效和耐药性的影响.
- 突出旨在克服ADC耐药性的新兴策略,以改善患者的治疗结果.
主要方法:
- 关于研究抗体-药物结合物 (ADC) 耐药性在血液性恶性瘤中的研究的文献综述.
- 分析导致ADC耐药性的分子机制,包括细胞和微环境因素.
- 综合当前和未来的治疗策略,以对抗ADC耐药性.
主要成果:
- 发现的关键抗性机制包括排泄过度表达,抗原降低调节,毒品贩运受损和改变的亡.
- 瘤微环境在培养耐药性和降低ADC有效性方面发挥着关键作用.
- 新兴的策略包括组合疗法,新型ADC设计和生物标志物引导的患者选择.
结论:
- 了解ADC耐药性的多方面的机制对于优化当前治疗方法至关重要.
- 开发克服耐药性的策略对于提高ADC在血液恶性瘤中的长期疗效至关重要.
- 未来的研究应该专注于个性化方法和下一代ADC,以改善患者的反应.
关键词:
这些ADC是ADCs.扩散性大B细胞淋巴瘤杰姆图祖马布 (Gemtuzumab) 是一种奥佐胺的药物.霍奇金淋巴瘤是一种霍奇金淋巴瘤.伊诺图祖马布 (Ozotuzumab Ozogamicin) 是一种可靠的药物.电阻 电阻 电阻 电阻 电阻 电阻更多相关视频
14:51Pooled shRNA Library Screening to Identify Factors that Modulate a Drug Resistance Phenotype
Published on: June 17, 2022
3.5K
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
7.5K
相关概念视频
Treatment Resistant Cancers
3.7K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.7K
Bone Marrow Sampling and Transplants
809
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
809
Targeted Cancer Therapies
8.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
8.6K
Cancer Therapies
9.8K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
9.8K
Combination Therapies and Personalized Medicine
5.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.8K
